članak: 1 od 1  
Medicinski glasnik Specijalna bolnica za bolesti štitaste žlezde i bolesti metabolizma Zlatibor
2007, vol. 12, br. 21, str. 36-46
jezik rada: srpski
neklasifikovan
Hipertenzivna kriza
Univerzitet u Beogradu, Medicinski fakultet, Klinički centar Srbije

Sažetak

Hipertenzivna kriza predstavlja urgentno stanje, cesto životno ugrožavajuće, koje se karakteriše povišenim vrednostima krvnog pritiska preko 180/120-140mmHg. U osnovi svake hipertenzivne krize se nalazi teška, maligna (akcelerirajuća) hipertenzija. Dva osnovna tipa hipertenzivne krize su: hipertenzivne kriza I reda hitnosti (hypertensive emergencies) i hipertenzivna kriza II stepena hitnosti (hypertensive urgencies). U patofiziološkom smislu poremećaj autoregulacije sistemske cirkulacije na nivou arteriolola je uzrok oba oblika hipertenzivne krize. U patoanatomskom smislu I red hitnosti se ispoljava kao hipertenzivna retinopatija ili hipertenzivna encefalopatija, što znaci da uvek postoji oštećenje ciljnih organa. Kod hipertenzivnih kriza II reda hitnostima nema znakova oštećenja ciljnih organa već samo skok vrednosti krvnog pritiska. Kratkoročni i dugoročni rizik od nastajanja nepoželjnih kardiovaskularnih i cerberovaskularnih događaja je značajno veći kod hipertenzivnih kriza I reda hitnosti. U ovom revijalnog rada su prikazani ne samo patofiziološki mehanizmi nastanka hipertenzivne krize i kliničke manifestacije već i način lečenja. Hipertenzivne krize I reda hitnosti se uvek leče parenteralnim lekovima uz obaveznu hospitalizaciju. Hipertenzivne krize II reda hitnosti se prvenstveno tretiraju peroralnim lekovima i moguće je uspešno lečenja i u ustanovama primarne zdravstvene zaštite.

Ključne reči

Reference

Ahmed, M.E., Walker, J.M., Beevers, D.G., Beevers, M. (1986) Lack of difference between malignant and accelerated hypertension. Br Med J (Clin Res Ed), 292(6515): 235-7
Angeli, P., Chiesa, M., Caregaro, L., Merkel, C., Sacerdoti, D., Rondana, M., Gatta, A. (1991) Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial. Arch Intern Med, 151(4): 678-82
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., i dr. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA, 289(19): 2560-72
Dimković, S., i dr. (2005) Arterijska hipertenzija. Beograd: Srpsko lekarsko društvo
Dodson, P.M., Lip, G.Y., Eames, S.M., Gibson, J.M., Beevers, D.G. (1996) Hypertensive retinopathy: A review of existing classification systems and a suggestion for a simplified grading system. J Hum Hypertens, 10(2): 93-8
European Society of Hypertension-European Society of Cardiology Guidelines Committee (2003) 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 21(6): 1011-53
Kaplan, N.M., Rose, B. (2006) Hypertensive emergencies: Malignant hypertension and hypertensive encephalopathy. UpToDate14, www.uptodate.com (800)998-6374. (781)237-4788
Kaplan, N.M. (1994) Management of hypertensive emergencies. Lancet, 344(8933): 1335-8
Kaplan, N.M., Bakris, G.L. (2006) Management of severe asymptomatic hypertension (hypertensive urgencies). UpToDate 14. 3, www. uptodate. com (800)998-6374. (781)237-4788
Kaplan, N.M. (2005) Systemic hypertension: Mechanism and diagnosis. u: Zipes P.D., Libby P., Bonow R.O.Braunwald E. (ur.) Braunwalds Heart Disease. A Textbook of Cardiovascular Medicine, Philadelphia: Elsevier Saunders
Katon, W., Roy-Byrne, P.P. (1989) Panic disorder in the medically ill. J Clin Psychiatry, 50(8): 299-302
Lenders, J.W.M., Pacak, K., Walther, M.M., Linehan, M.W., Mannelli, M., Friberg, P., Keiser, H.R., Goldstein, D.S., Eisenhofer, G. (2002) Biochemical diagnosis of pheochromocytoma: Which test is best?. JAMA, 287(11): 1427-34
Montgomery, H.E., Kiernan, L.A., Whitworth, C.E., Fleming, S., Unger, T., Gohlke, P., Mullins, J.J., McEwan, J.R. (1998) Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27. J Hypertens, 16(5): 635-43
Patel, R., Ansari, A., Grim, C.E., Hidaka, M. (1990) Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. Am J Cardiol, 66(10): 868-9
Rordorf, G., Macdonald, C. (2005) Hypertensive intracerebral hemorrhage. UpToDate 13.1., www. uptodate.com
Sharrett, A.R., Hubbard, L.D., Cooper, L.S., Sorlie, P.D., Brothers, R.J., Nieto, F.J., Pinsky, J.L., Klein, R. (1999) Retinal arteriolar diameters and elevated blood pressure: The Atherosclerosis Risk in Communities Study. Am J Epidemiol, 150(3): 263-70
Strandgaard, S., Paulson, O.B. (1989) Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens, 2(6 Pt 1): 486-92
Vaughan, C.J., Delanty, N. (2000) Hypertensive emergencies. Lancet, 356(9227): 411-7
Wong, T.Y., Klein, R., Sharrett, R.A., Duncan, B.B., Couper, D.J., Klein, B.E.K., Hubbard, L.D., Nieto, J.F., Atherosclerosis Risk in Communities Study (2004) Retinal arteriolar diameter and risk for hypertension. Ann Intern Med, 140(4): 248-55